Skip to main content
. 2014 Nov 1;32(51):6963–6970. doi: 10.1016/j.vaccine.2014.10.055

Table 1.

Demographic and clinical features of enrolled cases. The number of positives is reported along with the proportion in all cases. Where appropriate the mean and the standard deviation is reported instead. Where information on clinical features in some reports the reduced sample size of complete reports is given.

RCP
Non-RCP
Pre-vaccine period Post-vaccine period P value* Pre-vaccine period Post-vaccine period P value*
N = 126 N = 40 N = 2136 N = 785
Age <60 month
Male 67 (53%) 19 (48%) 0.53 1296 (61%) 467 (60%) 0.56
Age <24 month 92 (73%) 24 (60%) 0.12 1554 (73%) 562 (72%) 0.53
Kindergarten attended 60 (48%) 24 (60%) 0.17 895 (42%) 321 (41%) 0.62



Clinical features
Increased respiratory rate 39 (31%) 5 (13%) 0.02 379 (18%) 70 (9%) <0.001
Chest indrawing 13 (10%) 1 (3%) 0.19 123 (6%) 38 (5%) 0.34
Stridor 2 (2%) 0 (0%) 1 13 (1%) 10 (1%) 0.07
Body temperature ≥38.0 °C 94 (75%) 18 (45%) <0.001 1336 (63%) 282 (36%) <0.001
Pre-hospital antibiotics 38 (45%) 14 (41%) 0.73 617 (42%) 342 (47%) 0.03
Days from onset to admission 3.1 ± 2.6 3 ± 3.3 0.88 3.1 ± 2.9 2.3 ± 2.5 <0.001
WBC count, x10^3 16.8 ± 8.8 16 ± 8.6 0.59 12.8 ± 6.9 13.1 ± 7.3 0.31
Any virus 72 (61%) 25 (64%) 0.73 1287 (62%) 491 (67%) 0.01
RCP
Non-RCP
Pre-vaccine period Post-vaccine period P value* Pre-vaccine period Post-vaccine period P value*
N = 92 N = 24 N = 1554 N = 561
Age <24 month
Male 51 (55%) 14 (58%) 0.8 985 (63%) 351 (63%) 0.73
Kindergarten attended 39 (42%) 10 (42%) 0.95 470 (30%) 155 (28%) 0.25



Clinical features
Increased respiratory rate 30 (33%) 3 (13%) 0.07 287 (18%) 52 (9%) <0.001
Chest indrawing 9 (10%) 0 (0%) 0.2 98 (6%) 29 (5%) 0.33
Stridor 2 (2%) 0 (0%) 1 10 (1%) 5 (1%) 0.55
Body temperature ≥38.0 °C 69 (75%) 10 (42%) 0.002 947 (61%) 181 (32%) <0.001
Pre-hospital antibiotics 27 (44%) 9 (43%) 0.91 420 (40%) 237 (46%) 0.016
Days from onset to admission 3.3 ± 2.8 2.6 ± 3.1 0.34 3.2 ± 3.0 2.4 ± 2.5 <0.001
WBC count, ×103 17.2 ± 8.9 15.3 ± 8.8 0.33 13.0 ± 6.6 13.5 ± 7.8 0.2
Any virus 60 (68%) 18 (75%) 0.52 957 (63%) 367 (66%) 0.21
RCP
Non-RCP
Pre-vaccine period Post-vaccine period P value* Pre-vaccine period Post-vaccine period P value*
N = 34 N = 16 N = 582 N = 224
Age 24–59 month
Male 16 (47%) 5 (31%) 0.37 311 (53%) 116 (52%) 0.67
Kindergarten attended 21 (62%) 14 (88%) 0.1 425 (73%) 166 (74%) 0.76



Clinical features
Increased respiratory rate 9 (26%) 2 (13%) 0.47 92 (16%) 18 (8%) 0.004
Chest indrawing 4 (12%) 1 (6%) 1 25 (4%) 9 (4%) 0.86
Stridor 0 (0%) 0 (0%) 1 3 (1%) 5 (2%) 0.042
Body temperature ≥38.0 °C 25 (74%) 8 (50%) 0.1 389 (67%) 101 (45%) <0.001
Pre-hospital antibiotics 11 (46%) 5 (38%) 0.74 197 (50%) 105 (51%) 0.89
Days from onset to admission 2.5 ± 2.2 3.5 ± 3.5 0.27 2.8 ± 2.6 2.2 ± 2.3 0.002
WBC count, ×103 15.8 ± 8.3 17.0 ± 8.4 0.61 12.2 ± 7.6 12.2 ± 6.0 1
Any virus 12 (40%) 7 (44%) 0.81 330 (58%) 151 (68%) 0.008
*

Chi-square tests for categorical variables and t-tests for numerical variables as appropriate.

Definitions: Chest indrawing: child's chest wall moves in or retracts during inhalation; increased respiratory rate for children younger than 2 month is defined as at least 60 breaths per minute, for children 2–12 month olds at least 50 breaths per minute, and for children older than 12 months at least 40 breaths per minute; antibiotic usage within 14 days prior to admission is recognised here as possibly affecting the susceptibility to bacterial pneumonia.